The investigation for the improvement of muscle mass and muscle strength using a branched-chain amino acid (BCAA)-enriched nutrient (Aminoleban EN) in patients with liver cirrhosis associated with liver encephalopathy
Not Applicable
- Conditions
- decompensated liver cirrhosis
- Registration Number
- JPRN-UMIN000018278
- Lead Sponsor
- shonan kamakura general hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
1.Patients treated with albumin preparation. 2.Cirrhotic patients with less than 2.5 g/dl of serum albumin level. 3. Cirrhotic patients with more than 3.0 g/dl of serum bilirubin level. 4. Cirrhotic patients with more than third degree liver encephalopathy 5.Patients with history of hypersensitive against drugs. 6.Patients judged to be inappropriate for the study by the investigator.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change of muscle mass and muscle strength after administration of the agent
- Secondary Outcome Measures
Name Time Method 1)Change of blood cell count(WBC, RBC, lymphocyte, Plt) 2)Rate of side effect 3)compliance